Although 25–50% of patients are screened in the early stages of cancer, its recurrence or metastasis results in a low patient survival rate within 5 years, and there is a significant trend towards younger age of onset [ 2 , 3 ].
← all excerpts
The Inhibitory Effect and Mechanism of the Histidine-Rich Peptide rAj-HRP from <i>Apostichopus japonicus</i> on Human Colon Cancer HCT116 Cells.
1
—
—